Literature DB >> 31501249

Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.

A E Gregory1, E J van Schaik1, K E Russell-Lodrigue2, A P Fratzke1, J E Samuel3.   

Abstract

Coxiella burnetii, the etiological agent of Q fever, is a Gram-negative bacterium transmitted to humans by inhalation of contaminated aerosols. Acute Q fever is often self-limiting, presenting as a febrile illness that can result in atypical pneumonia. In some cases, Q fever becomes chronic, leading to endocarditis that can be life threatening. The formalin-inactivated whole-cell vaccine (WCV) confers long-term protection but has significant side effects when administered to presensitized individuals. Designing new vaccines against C. burnetii remains a challenge and requires the use of clinically relevant modes of transmission in appropriate animal models. We have developed a safe and reproducible C. burnetii aerosol challenge in three different animal models to evaluate the effects of pulmonary acquired infection. Using a MicroSprayer aerosolizer, BL/6 mice and Hartley guinea pigs were infected intratracheally with C. burnetii Nine Mile phase I (NMI) and demonstrated susceptibility as determined by measuring bacterial growth in the lungs and subsequent dissemination to the spleen. Histological analysis of lung tissue showed significant pathology associated with disease, which was more severe in guinea pigs. Infection using large-particle aerosol (LPA) delivery was further confirmed in nonhuman primates, which developed fever and pneumonia. We also demonstrate that vaccinating mice and guinea pigs with WCV prior to LPA challenge is capable of eliciting protective immunity that significantly reduces splenomegaly and the bacterial burden in spleen and lung tissues. These data suggest that these models can have appreciable value in using the LPA delivery system to study pulmonary Q fever pathogenesis as well as designing vaccine countermeasures to C. burnetii aerosol transmission.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Coxiella burnetiizzm321990; MicroSprayer; Q fever; aerosol; intratracheal; large-particle aerosol

Mesh:

Substances:

Year:  2019        PMID: 31501249      PMCID: PMC6867829          DOI: 10.1128/IAI.00178-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation.

Authors:  A Jeevan; C T McFarland; T Yoshimura; T Skwor; H Cho; T Lasco; D N McMurray
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Effect of aerosolization on culturability and viability of gram-negative bacteria.

Authors:  J F Heidelberg; M Shahamat; M Levin; I Rahman; G Stelma; C Grim; R R Colwell
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

3.  The course of infection with Coxiella burneti.

Authors:  E H Derrick
Journal:  Med J Aust       Date:  1973-05-26       Impact factor: 7.738

4.  Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.

Authors:  Robert E Brennan; Kasi Russell; Guoquan Zhang; James E Samuel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  The Guinea pig model of legionnaires' disease.

Authors:  Paul H Edelstein
Journal:  Methods Mol Biol       Date:  2013

6.  Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection.

Authors:  Alexandra Elliott; Ying Peng; Guoquan Zhang
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

Review 7.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

8.  Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever.

Authors:  J C Williams; T A Hoover; D M Waag; N Banerjee-Bhatnagar; C R Bolt; G H Scott
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 9.  The pathophysiological basis and consequences of fever.

Authors:  Edward James Walter; Sameer Hanna-Jumma; Mike Carraretto; Lui Forni
Journal:  Crit Care       Date:  2016-07-14       Impact factor: 9.097

10.  Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.

Authors:  Eric R Lafontaine; Shawn M Zimmerman; Teresa L Shaffer; Frank Michel; Xiudan Gao; Robert J Hogan
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  6 in total

1.  Proteomic Analysis of Non-human Primate Peripheral Blood Mononuclear Cells During Burkholderia mallei Infection Reveals a Role of Ezrin in Glanders Pathogenesis.

Authors:  Chih-Yuan Chiang; Yang Zhong; Michael D Ward; Douglas J Lane; Tara Kenny; Raysa Rosario-Acevedo; Brett P Eaton; Sylvia R Treviño; Taylor B Chance; Meghan Hu; Patricia L Worsham; David M Waag; Richard T Moore; Lisa H Cazares; Christopher K Cote; Yingyao Zhou; Rekha G Panchal
Journal:  Front Microbiol       Date:  2021-04-22       Impact factor: 5.640

2.  Air pollution and airborne infection with mycobacterial bioaerosols: a potential attribution of soot.

Authors:  J Noda; S Tomizawa; K Takahashi; K Morimoto; S Mitarai
Journal:  Int J Environ Sci Technol (Tehran)       Date:  2021-02-21       Impact factor: 2.860

3.  Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses.

Authors:  Alycia P Fratzke; Sharon Jan; Jiin Felgner; Li Liang; Rie Nakajima; Algis Jasinskas; Saikat Manna; Fnu N Nihesh; Sampa Maiti; Tyler J Albin; Aaron P Esser-Kahn; D Huw Davies; James E Samuel; Philip L Felgner; Anthony E Gregory
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

4.  Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity.

Authors:  Anthony E Gregory; Erin J van Schaik; Alycia P Fratzke; Kasi E Russell-Lodrigue; Christina M Farris; James E Samuel
Journal:  Cell Rep Med       Date:  2021-12-06

5.  Coxiella burnetii Whole Cell Vaccine Produces a Th1 Delayed-Type Hypersensitivity Response in a Novel Sensitized Mouse Model.

Authors:  Alycia P Fratzke; Anthony E Gregory; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

Review 6.  Preclinical Animal Models for Q Fever Vaccine Development.

Authors:  Mahelat Tesfamariam; Picabo Binette; Carrie Mae Long
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.